| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.29▼ | 3.29▼ | 3.29▼ | 3.35▼ | 3.22▲ |
| MA10 | 3.46▼ | 3.50▼ | 3.49▼ | 3.37▼ | 2.82▲ |
| MA20 | 3.54▼ | 3.40▼ | 3.33▼ | 3.15▲ | 2.82▲ |
| MA50 | 3.09▲ | 3.08▲ | 3.08▲ | 2.75▲ | 3.32▼ |
| MA100 | 3.01▲ | 2.83▲ | 2.74▲ | 2.79▲ | 7.90▼ |
| MA200 | 2.74▲ | 2.81▲ | 2.83▲ | 3.15▲ | 27.07▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.080▼ | -0.057▼ | -0.049▼ | -0.004▼ | 0.161▲ |
| RSI | 45.250▼ | 49.253▼ | 50.209▲ | 53.720▲ | 52.779▲ |
| STOCH | 4.211▼ | 3.786▼ | 8.964▼ | 54.987 | 70.482 |
| WILL %R | -95.775▼ | -95.775▼ | -95.775▼ | -50.350 | -40.223 |
| CCI | -98.323 | -104.283▼ | -85.825 | 24.498 | 127.497▲ |
|
Tuesday, June 02, 2026 06:12 PM
BioLine Rx Ltd (BLRX) reports increased revenue and APHEXDA sales, while navigating a net loss and competitive pressures in the glioblastoma treatment landscape.
|
|
Friday, May 29, 2026 06:36 PM
Initiation of a Phase I/IIa first-in-human trial for GLIX1 in glioblastoma (GBM) was announced, with the first patient dosed at NYU Langone Health; two additional academic centers (Northwestern ...
|
|
Thursday, May 28, 2026 12:17 PM
By John Vandermosten, CFA NASDAQ: BLRX READ THE FULL BLRX RESEARCH REPORT BioLineRx Ltd. (NASDAQ: BLRX) reported first quarter 2026 financial and operational results in a May 27th press release. For ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/06/26 | 3.39 | 3.4799 | 3.14 | 3.23 | 6,703 |
| 04/06/26 | 3.25 | 3.36 | 3.18 | 3.36 | 20,915 |
| 03/06/26 | 3.38 | 3.41 | 3.235 | 3.28 | 19,748 |
| 02/06/26 | 3.334 | 3.40 | 3.28 | 3.39 | 22,316 |
| 01/06/26 | 3.77 | 3.77 | 3.44 | 3.48 | 50,721 |
| 29/05/26 | 3.60 | 3.95 | 3.455 | 3.78 | 106,751 |
| 28/05/26 | 3.275 | 3.86 | 3.1801 | 3.59 | 95,498 |
| 27/05/26 | 3.30 | 3.37 | 3.02 | 3.37 | 94,949 |
| 26/05/26 | 3.20 | 3.37 | 3.0901 | 3.16 | 58,328 |
| 22/05/26 | 2.88 | 3.06 | 2.8705 | 3.06 | 55,038 |
|
|
||||
|
|
||||
|
|